Active	Status	Sponsor type	Region	Phase	Filter
12 Active 0 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Loomes, Kathleen
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai	Completed	2	75	Europe, US, RoW	Maralixibat, Formerly LUM001 and SHP625, Placebo	Mirum Pharmaceuticals, Inc.	Biliary Atresia	11/23	02/24
LEAP, NCT06193928: Long-Term Safety and Clinical Outcomes of Livmarli in Patients With Alagille Syndrome	Recruiting	N/A	50	US	Maralixibat	Mirum Pharmaceuticals, Inc.	Alagille Syndrome	09/28	09/28
Rogers, Michael
No trials found